Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 618 results for "warner chilcott"

WARNER CHILCOTT LTD - 10-Q - MANAGEMENT'S DISCUSSION AND ANALY...

(Edgar Glimpses Via Acquire Media NewsEdge) The following discussion of our financial condition and the results of operations should be read in conjunction with the "Consolidated Financial Statements" and notes thereto included elsewhere in this ... TMC Net, 1 month ago
Pharma Letter

Actavis' third-quarter sales jump 83 percent, lifted by Forest, Warner Chilcott acquisitions

Actavis announced Wednesday that third-quarter sales surged 83 percent year-over-year to $3.7 billion, boosted by products gained from the acquisitions of Forest Laboratories and Warner Chilcott, and topping analyst estimates of $3.6 billion. The ...
 FirstWord Pharma1 month ago Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition  Stockwatch1 week ago Actavis Net Revenue Increases 83% to $3.7 Billion in Third Quarter 2014; Non-GAAP EPS Increases 53% to $3.19  4 Traders1 month ago Actavis third-qtr sales rocket, but loss posted  Pharma Letter1 month ago
[x]  

69.5% Return Seen to Date on SmarTrend Warner Chilcott Call (WCRX)

(SmarTrend(R) Spotlight via COMTEX News Network) -- SmarTrend identified an Uptrend for Warner Chilcott (NASDAQ:WCRX) on January 17th, 2013 at $13.53. In approximately 23 months, Warner Chilcott has returned 69.54% as of today's recent price of ...
 PredictWallStreet3 weeks ago Warner Chilcott Has Returned 69.5% Since SmarTrend Recommendation (WCRX)  Comtex SmarTrend1 month ago Warner Chilcott Up 69.5% Since SmarTrend Uptrend Call (WCRX)  Comtex SmarTrend1 month ago

8-K/A - Warner Chilcott Ltd (0001620602) (Filer)

Document Format Files Seq Description Document Type Size 1 FORM 8-K/A d822647d8ka.htm 8-K/A 43564 2 EX-99.1 d822647dex991.htm EX-99.1 583802 3 EX-99.2 d822647dex992.htm EX-99.2 250910 Complete submission text file
 SEC Filings1 month ago 8-K - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings1 month ago 424B3 - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings2 months ago EFFECT - Warner Chilcott Ltd (0001620602) (Filer)  SEC Filings2 months ago

Mylan Launches Generic Oral Contraceptive Loestrin 24 Fe

Mylan said it recently launched a generic version of Warner Chilcott's oral contraceptive Loestrin 24 Fe in the U.S., following final FDA approval. The launch comes as brandmaker Actavis, which purchased Warner Chilcott last year, continues to ...
 FDA News1 month ago Mylan launches generic version of oral contraceptive  Individual.com1 month ago Mylan ships Loestrin 24 Fe generic  Chain Drug Review1 month ago Mylan introduces generic Loestrin 24 Fe in US markets  PharmaBiz1 month ago
[x]  

Northern Ireland link to 'Luxleaks' tax scheme

Pharmaceutical firm Warner Chilcott, which has strong links to Northern Ireland , has emerged as one of hundreds of companies to have availed of complex tax-saving arrangements in Luxembourg. Warner Chilcott , now part of US firm Actavis , entered ...
 4 Traders1 month ago

Actavis rides success of branded drugs and M&A to positive Q3

Actavis ($ACT) has been on an M&A kick, inking deals with Forest Laboratories ($FRX) and Warner Chilcott to get its hands on branded products. Now, the company can celebrate the fruits of that labor. Revenue for the quarter rang in at $3.68 ...
 FiercePharma1 month ago

Mylan (MYL) Launches Generic Formulation of Warner Chilcott's Loestrin 24 Fe

Visit StreetInsider.com at http://www.streetinsider.com/news.php-st=p&id=9976962 for the
 Wall Street Business Network1 month ago
[x]  

Q&A with Actavis and Allergan CEOs Following Blockbuster Dea…

On November 17, in what would be the year's largest acquisition in any industry, Actavis announced plans to acquire Allergan for $66 billion in cash and stock. Actavis, a specialty and generic drug maker, said it would pay $219 per Allergan ...
 Retina Today2 days ago

Pay-For-Delay In 2014: Courts Fill In The Actavis Gaps

A little more than one year ago, the U.S. Supreme Court decided Federal Trade Commission v. Actavis Inc .[1] and affirmed that antitrust principles apply to reverse payment settlement agreements — those in which a brand-name drug manufacturer pays ...
 JD Supra3 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less